Nanopublications

@prefix ns1: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RAuHGKz51vRfd5IBkW1pBxISJDvSxLIDS-kwmTfL85K8c> .
@prefix sub: <http://purl.org/np/RAuHGKz51vRfd5IBkW1pBxISJDvSxLIDS-kwmTfL85K8c#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix nkg: <https://w3id.org/um/neurodkg/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}

sub:assertion {
  sub:association rdf:object <https://identifiers.org/MONDO:0006642> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/CHEBI:52993> ;
    a rdf:Statement ;
    rdfs:label "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting (adjunct or breakthrough), as well as psychogenic catatonia." ;
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
    bl:has_population_context sub:cohort ;
    bl:provided_by "NeuroDKG" ;
    bl:publications <https://pubmed.ncbi.nlm.nih.gov/30422485/> ;
    bl:relation nkg:OffLabelIndication .
  sub:cohort rdfs:label "Adults" ;
    bl:category bl:Cohort .
  <https://identifiers.org/CHEBI:52993> bl:category bl:Drug .
  <https://identifiers.org/MONDO:0006642> bl:category bl:Disease .
}

sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" ;
    npx:hasSignature "CqKUmQjVJIy7d4BKbZtNI2P7RJ7WipUH00kRQn8Q0lNXYQqs56FJ3/IWYh5nohxla5/gp0KS6QX8jEvLukT9cZOjCOGfhDF8o4CSBp+Ov7WicgIVnEB9zyVtUg8li9kZFmn0juBKtZ7P/4V9MBsitvpX7IPCCB3W4UO83JAA588=" ;
    npx:hasSignatureTarget this: .
  this: ns1:created "2021-03-22T10:56:37.839+01:00"^^xsd:dateTime ;
    ns1:creator orcid:0000-0002-7641-6446 ;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM> ;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM> ;
    nt:wasCreatedFromTemplate <http://purl.org/np/RA59AEpaWRaR9sjdA0-n4zaQWdiZ6--iGafMrjrDAOheI> .
}